JOHNSON & JOHNSON - 8-K Filing
Johnson & Johnson reports Q3 2026 results with $25.4B in sales, raises full-year guidance due to strong operational performance (Items: 2.02 Results of operations and financial conditionOn October 13, 2026, Johnson & Johnson (the “Company”) issued the attached press release (Exhibi, 9.01 Financial statements and exhibits(d) Exhibits)
Coverage
- Core Scientific, Inc./tx - 8-K Filing
- Kontoor Brands, Inc. - 8-K Filing
- Vontier Corp - 8-K Filing
- MARRIOTT VACATIONS WORLDWIDE Corp - 8-K Filing
- INTERNATIONAL FLAVORS & FRAGRANCES INC - 8-K Filing
- ENTERGY LOUISIANA, LLC - 8-K Filing
- ENTERGY NEW ORLEANS, LLC - 8-K Filing
- ENTERGY MISSISSIPPI, LLC - 8-K Filing
- nVent Electric plc - 8-K Filing
- OSHKOSH CORP - 8-K Filing
- RAYMOND JAMES FINANCIAL INC - 8-K Filing
- PLEXUS CORP - 8-K Filing
- STERLING INFRASTRUCTURE, INC. - 8-K Filing
- GLAUKOS Corp - 8-K Filing
- CONMED Corp - 8-K Filing
- OLD DOMINION FREIGHT LINE, INC. - 8-K Filing
- Fortive Corp - 8-K Filing
- Bausch & Lomb Corp - 8-K Filing
- Urban Edge Properties - 8-K Filing
- DANA Inc - 8-K Filing
- GARMIN LTD - 8-K Filing
- Aon plc - 8-K Filing
- TE Connectivity plc - 8-K Filing
- ROYAL CARIBBEAN CRUISES LTD - 8-K Filing
- INNIO N.V. - 8-K Filing
- PENTAIR plc - 8-K Filing
- Johnson Controls International plc - 8-K Filing
- CORNING INC /NY - 8-K Filing
- KAISER ALUMINUM CORP - 8-K Filing
- STEWART INFORMATION SERVICES CORP - 8-K Filing
- QuantumScape Corp - 8-K Filing
- UDR, Inc. - 8-K Filing
- ABBOTT LABORATORIES - 8-K Filing
- NORTHROP GRUMMAN CORP /DE/ - 8-K Filing
- MAXCYTE, INC. - 8-K Filing
- Johnson & Johnson Reports Earnings Beat but GAAP Profit Plummets, Sending Stock Down
- JOHNSON & JOHNSON - 8-K Filing